ImageneBio (IMA) Profit After Tax (2020 - 2025)

ImageneBio has disclosed Profit After Tax across 6 years of filings, most recently posting -$24.8 million for Q3 2025.

• Profit After Tax for Q3 2025 came in at -$24.8 million, down 678.48% year-over-year; the trailing twelve-month figure through Sep 2025 was -$55.9 million (down 9.05% YoY), and the FY2024 annual result was -$49.2 million, up 27.82% from the prior year.
• Profit After Tax came in at -$24.8 million for Q3 2025 at ImageneBio, down from -$7.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $2.8 million in Q4 2021 to a low of -$24.8 million in Q3 2025.
• The 5-year median for Profit After Tax is -$14.5 million (2021), against an average of -$13.6 million.
• Across the five-year window, Profit After Tax soared 110.74% in 2021 and slumped 678.48% in 2025, its largest moves.
• ImageneBio's Profit After Tax stood at $2.8 million in 2021, then slumped by 604.0% to -$14.1 million in 2022, then slumped by 38.25% to -$19.5 million in 2023, then grew by 10.49% to -$17.4 million in 2024, then slumped by 42.05% to -$24.8 million in 2025.
• The last three Profit After Tax figures came in at -$24.8 million (Q3 2025), -$7.6 million (Q2 2025), and -$6.1 million (Q1 2025), per Business Quant data.